Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion type Assertion NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_head.
- NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion description "[We aim to pharmacologically downregulate heat shock protein 27 (HSP27) through triptolide (TPL) to improve the drug sensitivity of pancreatic cancer to cisplatin (DDP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_provenance.
- NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion evidence source_evidence_literature NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_provenance.
- NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion SIO_000772 22617708 NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_provenance.
- NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion wasDerivedFrom befree-20140225 NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_provenance.
- NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_assertion wasGeneratedBy ECO_0000203 NP616267.RAVxwi9B3tT2MnYnW2Pz2zssjm1ETrE3lBRsCD-aC45KY130_provenance.